Holen Sie sich die Stockscreener-App
3.99
1.79%
0.07
Schlusskurs vom Vortag:
$3.92
Offen:
$3.91
24-Stunden-Volumen:
161.46K
Relative Volume:
0.52
Marktkapitalisierung:
$238.92M
Einnahmen:
$32.72M
Nettoeinkommen (Verlust:
$-54.64M
KGV:
-3.5382
EPS:
-1.1277
Netto-Cashflow:
$-55.08M
1W Leistung:
-4.77%
1M Leistung:
-0.75%
6M Leistung:
-16.87%
1J Leistung:
+33.00%
1-Tages-Spanne:
$3.81
$4.00
1-Wochen-Bereich:
$3.80
$4.25
52-Wochen-Spanne:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.99 | 238.92M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Eingeleitet | TD Cowen | Buy |
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Price to earnings forward of Orchestra BioMed Holdings, Inc. – BOATS:OBIO - TradingView
OBIOOrchestra BioMed Holdings Inc Latest SEC Filings - Finviz
Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Share Price, OBIO Stock News, OBIO Share Price & Updates - Kalkine
Insider Sell: Darren Sherman Sells 15,000 Shares of Orchestra Bi - GuruFocus
Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan - Stock Titan
Form 144 Orchestra BioMed Holdings For: 1 July By Investing.com - Investing.com South Africa
Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO) - Stock Titan
Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes - marketscreener.com
Orchestra BioMed Holdings' Market Cap Up US$40m Following Year Of Insider Stock Buying - simplywall.st
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Index - marketscreener.com
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2500 Growth Benchmark - marketscreener.com
Orchestra BioMed stock rises after Russell index addition By Investing.com - Investing.com Australia
Orchestra BioMed stock rises after Russell index addition - Investing.com
Orchestra BioMed (OBIO) Joins Russell 3000 and Russell 2000 Inde - GuruFocus
Orchestra BioMed joins Russell 2000 and 3000 indexes - Investing.com
Orchestra BioMed joins Russell 2000 and 3000 indexes By Investing.com - Investing.com Australia
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2000 Growth Benchmark - marketscreener.com
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Dynamic Index - marketscreener.com
Orchestra BioMed Holdings, Inc. Actuals & Estimates (NASDAQ:OBIO) - TradingView
Form 4 Orchestra Biomed Holdings Inc For: 25 June By Investing.com - Investing.com Nigeria
OBIO Forecast — Price Target — Prediction for 2027 - TradingView
Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld - Stock Titan
Orchestra BioMed (OBIO) director awarded RSUs and options with tax-share withholding - Stock Titan
Orchestra BioMed (OBIO) director logs RSU tax withholding and 42,553-option grant - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) director receives new RSU and stock option grants - Stock Titan
Orchestra BioMed (OBIO) director receives 42,553 stock options at $4.04 strike - Stock Titan
Orchestra BioMed (OBIO) director granted RSUs, shares withheld for taxes - Stock Titan
Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com - Investing.com India
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting By Investing.com - Investing.com Australia
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting - Investing.com South Africa
Orchestra BioMed Shareholders Approve Directors and Incentive Plan - TipRanks
Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items - Stock Titan
Orchestra BioMed Holdings (OBIO) Bounces from Support: +2.26% Gain Signals Potential RecoveryIV Expansion Alert - dars.gov.et
Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG - The Globe and Mail
Orchestra Biomed Holdings Inc (OBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orchestra Biomed Holdings Inc - TradingKey
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Recognition Risk - newsline.com
Orchestra BioMed (OBIO) Edges Higher, Testing Key Resistance Zone on Modest VolumeLow Beta Factor - newsline.com
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):